αααααβααΎαALPMF β’ OTCMKTS
add
Astellas Pharma Inc
9.52$
3 α§αααΆ, 5:20:00 PM ααααβααα -4 · USD · OTCMKTS · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·αααΆαααΈααααΆααααΆααααααΆααα
JP
αα·αααΈαα»α
9.52$
α
ααααααα½αααααΆαα
α»αααααα
9.13$ - 17.00$
ααΎαβαα»αβααΈααααΆα
2.82Β ααααΈααΆα JPY
ααα ααα½αααΌαααααα
1.60ααΆαα
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
TYO
αααα»αβααααααΆαβ
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (JPY) | ααααΌ 2023info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 421.93Β αααΈααΆα | 4.91% |
α
αααΆαααααα·ααααα·ααΆα | 327.17Β αααΈααΆα | 23.00% |
α
αααΌααα»ααα | 14.51Β αααΈααΆα | -70.02% |
ααααΆααα
αααααα»ααα | 3.44 | -71.43% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | β | β |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 65.85Β αααΈααΆα | -22.30% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 16.17% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (JPY) | ααααΌ 2023info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 285.44Β αααΈααΆα | -30.94% |
ααααααααα»α | 3.37Β ααααΈααΆα | 34.00% |
ααΆαααα½ααα»αααααΌαααα»α | 1.87Β ααααΈααΆα | 97.71% |
ααΌαβααααα»α | 1.50Β ααααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 1.79Β αααΈααΆα | β |
ααααααααααΉαααααα
| 0.01 | β |
ααα
ααααααΎαααααα | 1.36% | β |
ααα
ααααααΎααΎααα»α | 1.92% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (JPY) | ααααΌ 2023info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | 14.51Β αααΈααΆα | -70.02% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 51.41Β αααΈααΆα | -28.90% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | -40.31Β αααΈααΆα | -48.64% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -87.02Β αααΈααΆα | -798.18% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | -80.02Β αααΈααΆα | -485.74% |
ααα αΌαααΆα
αααααΆααααααα | 31.33Β αααΈααΆα | 428.72% |
α’αααΈ
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. On February 5, 2020, the company announced management changes effective from April 1, 2020.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
ααΆααααααΎαα‘αΎα
1 ααααΆ 2005
ααΆαα·ααΆαααβαααααΆα
αααααβαααααΆα
αα»ααααα·α
14,484
